Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Ngangue, P. Pilabré, A. H. Barro, A. Pafadnam, Y. Bationo, N. Soubeiga, D.

Public attitudes towards COVID-19 vaccines in Africa: A systematic review

  • Africa
  • Adults
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Ng, S. M. Pan, J. Mouyis, K. Kondapally Seshasai, S. R. Kapil, V. Rice, K. M. Gupta, A. K.

Quantifying the Excess Risk of Adverse COVID-19 Outcomes in Unvaccinated Individuals With Diabetes Mellitus, Hypertension, Ischaemic Heart Disease or Myocardial Injury: A Meta-Analysis

  • Adults
  • Low and Middle Income Countries
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2022 ∙ Oueijan, R. I. Hill, O. R. Ahiawodzi, P. D. Fasinu, P. S. Thompson, D. K.

Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Nguyen, T. T. Quach, T. H. T. Tran, T. M. Phuoc, H. N. Nguyen, H. T. Vo, T. K. Vo, G. V.

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Wang, K. Wang, L. Li, M. Xie, B. He, L. Wang, M. Zhang, R. Hou, N. Zhang, Y. Jia, F.

Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Sadeghalvad, M. Mansourabadi, A. H. Noori, M. Nejadghaderi, S. A. Masoomikarimi, M. Alimohammadi, M. Rezaei, N.

Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Mardiyan Kurniawati, E. Rahmawati, N. A.

Records of antibodies in breast milk in postpartum women who have been vaccinated or exposed to COVID-19: A systematic review

  • Parents/caregivers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Zhang, J. Cao, J. Ye, Q.

Renal Side Effects of COVID-19 Vaccination

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lane, S. Yeomans, A. Shakir, S.

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Parker, E. P. K. Desai, S. Marti, M. Nohynek, H. Kaslow, D. C. Kochhar, S. O'Brien, K. L. Hombach, J. Wilder-Smith, A.

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...